Former general counsel of Novo Nordisk joins Lowenstein Sandler

Law firm Lowenstein Sandler announced that James Shehan, former general counsel of Novo Nordisk, will join the firm as a senior counsel in its life sciences practice and as head of the firm’s FDA regulatory practice.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.